The US FDA has granted marketing authorization to the PMD-200 monitor developed by Israel’s Medasense Biometrics (see here previously). The device monitors pain in non-communicating (e.g., anaesthetized) patients and already has made an impact in multiple countries. https://www.calcalistech.com/ctechnews/article/hyfvzhsrs

Israel’s Medasense (see here) assesses levels of pain in non-communicative patients using its PMD200 pain monitoring device. The technology is now being advanced on ventilated COVID-19 patients. Medtronic is distributing the tech in Europe and FDA approval is in progress. … Continue reading →

The NOL pain monitoring technology from Israel’s Medasense (see here) helps clinicians treat non-communicating patients. The Israel Innovation Authority has just given Medasense a grant to test NOL at the Dorot Rehabilitation and Geriatric Medical Center in Netanya. https://finance.yahoo.com/news/medasense-pain-index-solution-treatment-121400637.html

I reported previously (Feb 2017) that the PMD200 pain measurement device from Israel’s Medasense had received European CE Approval. Now, the international Society of Critical Care Medicine has included the innovative technology in its Intensive Care Unit Clinical Practice Guidelines. … Continue reading →

I reported previously (May 2015) on the pain measurement device developed by Israel’s Medasense Biometrics.  The innovative PMD200 has now received CE approval, allowing physicians to assess and manage pain for patients who cannot communicate. http://www.medasense.com/medasense-launches-new-pain-monitoring-device-pmd200-following-european-ce-approval/

Israel’s MedaSense Biometrics won the WOW Competition (medical device category) for the most innovative startup at the IATA Biomed exhibition in May. MedaSense’s pain monitor uses a finger sensor to record vital signs and a unique algorithm to measure pain … Continue reading →

The Israeli innovations featured at the US road shows included Archmedical’s tissue sampler, BiFlow’s Nitino stent, Medasense’s pain monitor and Moebius’s injectable solution for osteo-arthritis. http://itrade.gov.il/us-ny/2013/02/13/roadshow-recap-2013-medical-device-innovations-nyc-boston/